Stocks and Investing Stocks and Investing
Fri, November 4, 2022
[ 12:00 AM ] - WOPRAI
Cristina Fernandez Maintained (UAA) at Hold with Increased Target to $9 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Kimberly Greenberger Maintained (UAA) at Hold with Decreased Target to $8 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Tejas Savant Maintained (TXG) at Buy with Decreased Target to $64 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
James Fish Maintained (TWLO) at Buy with Decreased Target to $79 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Rishi Jaluria Downgraded (TWLO) to Hold and Held Target at $55 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Derrick Wood Downgraded (TWLO) to Hold and Decreased Target to $65 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Siti Panigrahi Maintained (TWLO) at Strong Buy with Decreased Target to $75 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Michael Turrin Downgraded (TWLO) to Hold and Decreased Target to $60 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Michael Funk Maintained (TWLO) at Sell with Decreased Target to $70 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Patrick Walravens Maintained (TWLO) at Buy with Decreased Target to $110 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Ryan Lynch Downgraded (TRIN) to Hold and Decreased Target to $13 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Cecilia Furlong Maintained (TMDX) at Hold with Increased Target to $54 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Eric Stine Upgraded (TPIC) to Strong Buy on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Mayank Tandon Maintained (TREE) at Strong Buy with Decreased Target to $32 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Jayson Bedford Maintained (TNDM) at Buy with Decreased Target to $52 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Mayank Tandon Maintained (SQ) at Strong Buy with Decreased Target to $80 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
James Faucette Maintained (SQ) at Hold with Decreased Target to $67 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Daniel Perlin Maintained (SQ) at Buy with Decreased Target to $93 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Michael Ng Maintained (SQ) at Strong Buy with Decreased Target to $114 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Jeff Cantwell Maintained (SQ) at Buy with Decreased Target to $97 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Mayank Tandon Maintained (SPNS) at Strong Buy with Decreased Target to $22 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Peter Arment Downgraded (SPR) to Hold and Held Target at $29 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Michael Turits Maintained (SPT) at Buy with Decreased Target to $60 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Raimo Lenschow Maintained (SPT) at Buy with Decreased Target to $63 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Rob Oliver Maintained (SPT) at Buy with Decreased Target to $64 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Stan Zlotsky Maintained (SPT) at Hold with Decreased Target to $60 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Nick Setyan Maintained (STKS) at Buy with Decreased Target to $7.5 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Ben Haynor Maintained (SRTS) at Strong Buy with Decreased Target to $17 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Eric Luebchow Maintained (CCOI) at Sell with Decreased Target to $53 on, Nov 4th, 2022
[ 12:00 AM ] - WOPRAI
Eric Joseph Downgraded (CCCC) to Hold and Decreased Target to $15 on, Nov 4th, 2022

Eric Joseph Downgraded (CCCC) to Hold and Decreased Target to $15 on, Nov 4th, 2022


Published on 2024-10-27 23:55:41 - WOPRAI, Eric Joseph
  Print publication without navigation


Eric Joseph of JP Morgan, Downgraded "C4 Therapeutics, Inc." (CCCC) to Hold and Decreased Target from $22 to $15 on, Nov 4th, 2022.

Eric has made no other calls on CCCC in the last 4 months.



There is 1 other peer that has a rating on CCCC. Out of the 1 peers that are also analyzing CCCC, 0 agree with Eric's Rating of Hold.



This is the rating of the analyst that currently disagrees with Eric

  • Terence Flynn of "Morgan Stanley" Initiated at Sell and Held Target at $6 on, Tuesday, October 11th, 2022
Contributing Sources